リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Cell migration is impaired in XPA-deficient cells」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Cell migration is impaired in XPA-deficient cells

Takeuchi, Seiji Fukumoto, Takeshi Takemori, Chihiro Saito, Naoaki Nishigori, Chikako Sato, Makoto 神戸大学

2023.02

概要

Xeroderma pigmentosum (XP) is a hereditary disorder characterized by photosensitivity, predisposition to skin cancers, and neurological abnormalities including microcephaly and progressive neurodegeneration. A lack of nucleotide excision repair (NER) in patients with XP can cause hypersensitivity to the sun, leading to skin cancer, whereas the etiology of the neuronal symptoms of XP remains ambiguous. There are various neurological disorders that perturb neuronal migration, causing mislocalization and disorganization of the cortical lamination. Here, we investigated the role of the XP group-A (Xpa) gene in directed cell migration. First, we adopted an in utero electroporation method to transduce shRNA vectors into the murine embryonic cerebral cortex for the in vivo knockdown of Xpa. Xpa-knockdown neurons in the embryonic cerebral cortex showed abnormal cell migration, cell cycle exit, and differentiation. The genotype–phenotype relationship between the lack of XPA and cell migration abnormalities was confirmed using both a scratch assay and time-lapse microscopy in XP-A patient-derived fibroblasts. Unlike healthy cells, these cells showed impairment in overall mobility and the direction of motility. Therefore, abnormal cell migration may explain neural tissue abnormalities in patients with XP-A.

この論文で使われている画像

参考文献

1. Rizza ERH, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: a model for human premature aging. J Invest Dermatol. 2021;141(4S):976-­984.

2. Ueda T, Kanda F, Nishiyama M, Nishigori C, Toda T. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group a carrying the founder mutation in Japan. J Neurol Sci. 2017;381:103-­106.

3. Imoto K, Nadem C, Moriwaki S, et al. Ancient origin of a Japanese xeroderma pigmentosum founder mutation. J Dermatol Sci. 2013;69(2):175-­176.

4. Nishigori C, Nakano E, Masaki T, et al. Characteristics of Xeroderma Pigmentosum in Japan: lessons from two clinical surveys and measures for patient care. Photochem Photobiol. 2019;95(1):140-­153.

5. Nishigori C, Moriwaki S, Takebe H, Tanaka T, Imamura S. Gene alterations and clinical characteristics of xeroderma pigmentosum group a patients in Japan. Arch Dermatol. 1994;130(2):​ 191-­197.

6. Tsuji Y, Ueda T, Sekiguchi K, et al. Progressive length-­dependent polyneuropathy in xeroderma pigmentosum group a. Muscle Nerve. 2020;62(4):534-­540.

7. Brooks PJ. The case for 8,5′-­ cyclopurine-­ 2′-­ deoxynucleo sides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007;145(4):1407-­1417.

8. Kuraoka I, Robins P, Masutani C, et al. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J Biol Chem. 2001;276(52):49283-­49288.

9. Mori T, Nakane H, Iwamoto T, et al. High levels of oxidatively generated DNA damage 8,5′-­cyclo-­2′-­deoxyadenosine accumulate in the brain tissues of xeroderma pigmentosum group a gene-­knockout mice. DNA Repair (Amst). 2019;80:52-­58.

10. Fang EF, Scheibye-­Knudsen M, Brace LE, et al. Defective mitophagy in XPA via PARP-­1 hyperactivation and NAD(+)/SIRT1 reduction. Cell. 2014;157(4):882-­896.

11. Manandhar M, Lowery MG, Boulware KS, Lin KH, Lu Y, Wood RD. Transcriptional consequences of XPA disruption in human cell lines. DNA Repair (Amst). 2017;57:76-­90.

12. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84(3):359-­369.

13. Hwang HM, Ku RY, Hashimoto-­Torii K. Prenatal environment that affects neuronal migration. Front Cell Dev Biol. 2019;7:138.

14. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-­interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A. 2002;99(9):6047-­6052.

15. Nagano T, Morikubo S, Sato M. Filamin a and FILIP (Filamin A-­interacting protein) regulate cell polarity and motility in neocortical subventricular and intermediate zones during radial migration. J Neurosci. 2004;24(43):9648-­9657.

16. Ogawa H, Koyanagi-­Aoi M, Otani K, Zen Y, Maniwa Y, Aoi T. Interleukin-­6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells. Sci Rep. 2017;7(1):12317.

17. Tanioka M, Budiyant A, Ueda T, et al. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group a. J Invest Dermatol. 2005;125(2):244-­246.

18. Arseni L, Lanzafame M, Compe E, et al. TFIIH-­dependent MMP-­1 overexpression in trichothiodystrophy leads to extracellular matrix alterations in patient skin. Proc Natl Acad Sci U S A. 2015;112(5):1499-­1504.

19. Le May N, Mota-­Fernandes D, Velez-­Cruz R, Iltis I, Biard D, Egly JM. NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol Cell. 2010;38(1):54-­66.

20. Cimini A, Benedetti E, Cristiano L, et al. Expression of peroxisome proliferator-­activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience. 2005;130(2):325-­337.

21. Luo T, Wagner E, Drager UC. Integrating retinoic acid signaling with brain function. Dev Psychol. 2009;45(1):139-­150.

22. Choi J, Park S, Sockanathan S. Activated retinoid receptors are required for the migration and fate maintenance of subsets of cortical neurons. Development. 2014;141(5):1151-­1160.

23. Anttinen A, Koulu L, Nikoskelainen E, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008;131(Pt 8):1979-­1989.

参考文献をもっと見る